Literature DB >> 6102941

Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis.

A V Greco, L Altomonte, G Ghirlanda, A G Rebuzzi, R Manna, A Bertoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6102941     DOI： 10.1007/bf00251914

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  25 in total

1.  Inhibition of pancreatic glucagon release by somatostatin: in vitro.

Authors:  J Iversen
Journal:  Scand J Clin Lab Invest       Date:  1974-04       Impact factor: 1.713

2.  Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

Authors:  C H Mortimer; W M Tunbridge; D Carr; L Yeomans; T Lind; D H Coy; S R Bloom; A Kastin; C N Mallinson; G M Besser; A V Schally; R Hall
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

3.  Inhibition of insulin secretion by somatostatin.

Authors:  K G Alberti; N J Christensen; S E Christensen; A P Hansen; J Iversen; K Lundbaek; K Seyer-Hansen; H Orskov
Journal:  Lancet       Date:  1973-12-08       Impact factor: 79.321

4.  Behavior of pancreatic glucagon, insulin, and HGH in liver cirrhosis, after arginine and I.V. glucose.

Authors:  A V Greco; G Ghirlanda; C Patrono; G Fedili; R Manna
Journal:  Acta Diabetol Lat       Date:  1974 Jul-Aug

5.  Acute suppression of insulin and glucose levels by synthetic somatostatin in normal human subjects.

Authors:  G W DeVane; T M Siler; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1974-05       Impact factor: 5.958

6.  Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: studies with somatostatin.

Authors:  J E Gerich; M Lorenzi; S Hane; G Gustafson; R Guillemin; P H Forsham
Journal:  Metabolism       Date:  1975-02       Impact factor: 8.694

7.  Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.

Authors:  J E Liljenquist; G L Mueller; A D Cherrington; U Keller; J M Perry; W W Lacy; D Rabinowitz
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

8.  Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.

Authors:  J Wahren; S Efendić; R Luft; L Hagenfeldt; O Björkman; P Felig
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

9.  Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.

Authors:  J L Shurberg; R H Resnick; R S Koff; E Ros; R A Baum; J A Pallotta
Journal:  Gastroenterology       Date:  1977-02       Impact factor: 22.682

10.  Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.

Authors:  R S Sherwin; M Fisher; J Bessoff; N Snyder; R Hendler; H O Conn; P Felig
Journal:  Gastroenterology       Date:  1978-06       Impact factor: 22.682
View more
  1 in total

1.  Insulin binding to erythrocytes in hyperinsulinemic patients with precirrhotic hemochromatosis and cirrhosis.

Authors:  A S Petrides; W Passlack; H Reinauer; W Stremmel; G Strohmeyer
Journal:  Klin Wochenschr       Date:  1987-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.